Isotope selection for patients undergoing prostate brachytherapy
- 1 September 1999
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 45 (2) , 391-395
- https://doi.org/10.1016/s0360-3016(99)00187-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinomaCancer, 1998
- Radioisotopic implantation for carcinoma of the prostate: Does it work better than it used to?Seminars in Radiation Oncology, 1998
- Code of practice for brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 56Medical Physics, 1997
- Biochemical disease-free survival following 125I prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- 103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinomaCancer, 1996
- Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.Journal of Clinical Oncology, 1996
- Transperineal palladium 103 prostate brachytherapy: Analysis of morbidity and seed migrationUrology, 1995
- A nomograph for permanent implants of palladium-103 seedsInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Permanent implants using Au-198, Pd-103 and I-125: Radiobiological considerations based on the linear quadratic modelInternational Journal of Radiation Oncology*Biology*Physics, 1992